The
University of Colorado Cardiovascular Institute (CU-CVI) was founded in
1998 to integrate cardiovascular research and treatment effort between
the University of Colorado Denvers housed within Denver, Aurora, and Boulder
campuses and researchers within CU-CVI headquarters. Founded by Co-Directors, Michael
Bristow MD, PhD
and Leslie
Leinwand PhD,
the Institute serves as the umbrella under which physicians, basic
molecular biologists, and geneticists coalesce to share valuable
information and initiate effective treatment programs and preventive
therapies. This is accomplished by an extramural branch of CU-CVI that
includes the laboratories of investigators based at the component
campuses, and an intramural branch dedicated to molecular genetics
that is housed at the CU Fitzsimons campus in Aurora.
Unique in the history of the University, the Institute promotes
collaboration among scientists, allowing them to advance investigative
potential by networking and collaborating on high-quality and
large-scale cardiovascular research, training, and education programs.
By integrating the effort of those committed to curing heart muscle
disease and heart failure, the collaborative nature of the Institute
encourages the sharing of findings and data, which ultimately translate
into improved treatments and therapies of patients.
The scientific goals of the Institute are to understand the genetic basis and specific molecular mechanisms responsible for heart muscle disease and heart failure and to produce new diagnostic techniques and treatments for patients. A primary asset of CU-CVI is an in-house cardiac tissue bank and functional genomics database, which contains one of the largest human tissue collections in the world from explanted human hearts. Data generated from the tissue bank have produced discoveries by Institute scientists that have resulted in new diagnostic techniques and improvements in the way physicians and researchers worldwide approach and treat heart failure.
For any queries regarding this website contact Rachel M. Rosenberg
